Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.

Volume 3 (2006), Issue 6 (June)

1. Discriminant function based on hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhotic from non-cirrhotic liver diseased patients in chronic HCV infection.
   Clin Chim Acta, 369(1): 66-72. [Abstract] [Full-text]
2. Diagnostic accuracy of serum asialo-alpha1-acid glycoprotein concentration for the differential diagnosis of liver cirrhosis and hepatocellular carcinoma.
   Clin Chim Acta, 369(1): 46-51. [Abstract] [Full-text]
3. Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma.
   Int J Cancer, 119(4): 735-40. [Abstract] [Full-text]
4. Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats.
   Gut, 55(7): 1020-9. [Abstract] [Full-text]
5. Hepatic venous dysregulation contributes to blood volume pooling in cirrhotic rats.
   Gut, 55(7): 1030-5. [Abstract] [Full-text]
6. Effect of meal and propranolol on whole body and splanchnic oxygen consumption in patients with cirrhosis.
   Am J Physiol Gastrointest Liver Physiol, 291(1): G8-15. [Abstract] [Full-text]
7. 507 Warren-Zeppa distal splenorenal shunts: a 34-year experience.
   Ann Surg, 243(6): 884-92; discussion 892-4. [Abstract] [Full-text]
8. Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin.
   J Nutr Biochem, 17(7): 485-91. [Abstract] [Full-text]
9. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.
   J Intern Med, 260(1): 62-8. [Abstract] [Full-text]
10. Transgenic mice aberrantly expressing pyruvate dehydrogenase complex E2 component on biliary epithelial cells do not show primary biliary cirrhosis.
    Clin Exp Immunol, 145(1): 93-100. [Abstract] [Full-text]
11. Effects of bicyclol on dimethylnitrosamine-induced liver fibrosis in mice and its mechanism of action.
    Life Sci, 79(6): 606-12. [Abstract] [Full-text]
12. Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis.
    Biochem Biophys Res Commun, 346(3): 658-64. [Abstract] [Full-text]
13. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients.
    Clin Infect Dis, 43(3): 365-72. [Abstract] [Full-text]

© 2004-2008 Liver Cirrhosis Research Today. All Rights Reserved.